SLS Financials

Sellas Life Sciences Group Inc - Financial statements & key metrics

Stock Price

$13.31

Market Cap

$1.62B

P/E Ratio

-9.9

EPS

$-1.34

Income Statement Highlights

Most Recent Quarter: 2024-12-31

Revenue

Gross Profit

Operating Income

Net Income

$-30.88M

EPS (Diluted)

$-0.50

Balance Sheet Highlights

Total Assets

$19.43M

Total Liabilities

$9.97M

Shareholders Equity

Cash & Equivalents

$13.89M

Total Debt

Cash Flow Highlights

Operating Cash Flow

$-35.40M

CapEx

Free Cash Flow

Profitability Metrics

View Complete Financial Statements

Full income statements, balance sheets, and cash flows for multiple periods

Open Full Financials

Frequently Asked Questions

What is SLS revenue?

View SLS's income statement for detailed revenue data.

Is SLS profitable?

SLS reported a loss of $30.88M in the most recent quarter.

What is SLS market cap?

SLS has a market capitalization of $1.62B, making it a small-cap stock.

Does SLS have debt?

View SLS's balance sheet for debt information.

What is SLS cash flow?

Cash flow data is available in the full financial statements.